SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-080433
Filing Date
2023-03-27
Accepted
2023-03-27 16:05:59
Documents
15
Period of Report
2023-03-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d492831d8k.htm   iXBRL 8-K 23732
2 EX-99.1 d492831dex991.htm EX-99.1 10823
6 GRAPHIC g492831sp001.jpg GRAPHIC 11104
7 GRAPHIC g492831sp003.jpg GRAPHIC 9346
  Complete submission text file 0001193125-23-080433.txt   178806

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20230327.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20230327_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20230327_pre.xml EX-101.PRE 11263
9 EXTRACTED XBRL INSTANCE DOCUMENT d492831d8k_htm.xml XML 3368
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 23764573
SIC: 8090 Services-Misc Health & Allied Services, NEC